These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107. Carcinoid tumors: what should increase our suspicion? Aggarwal G; Obideen K; Wehbi M Cleve Clin J Med; 2008 Dec; 75(12):849-55. PubMed ID: 19088003 [TBL] [Abstract][Full Text] [Related]
108. Carcinoid tumor presenting as a primary mesenteric mass: a case report and review of the literature. Yamanuha J; Ballinger R; Coon D; Navin J Hawaii Med J; 2009 Jul; 68(6):137-9. PubMed ID: 19653425 [TBL] [Abstract][Full Text] [Related]
109. ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: pre- and perioperative therapy in patients with neuroendocrine tumors. Akerström G; Falconi M; Kianmanesh R; Ruszniewski P; Plöckinger U; ; Neuroendocrinology; 2009; 90(2):203-8. PubMed ID: 19713712 [No Abstract] [Full Text] [Related]
110. [Rectal carcinoids on the rise - update]. Scherübl H; Klöppel G Z Gastroenterol; 2009 Apr; 47(4):365-71. PubMed ID: 19358064 [TBL] [Abstract][Full Text] [Related]
111. Somatostatin analog octreotide LAR in gastro-entero-pancreatic tumors. Oberg K Expert Rev Anticancer Ther; 2009 May; 9(5):557-66. PubMed ID: 19445573 [TBL] [Abstract][Full Text] [Related]